DISC MEDICINE INC (IRON) Stock Fundamental Analysis

NASDAQ:IRON • US2546041011

61.36 USD
-1.99 (-3.14%)
At close: Feb 20, 2026
61.36 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

IRON gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. While IRON seems to be doing ok healthwise, there are quite some concerns on its profitability. IRON does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IRON has reported negative net income.
  • In the past year IRON has reported a negative cash flow from operations.
  • In the past 5 years IRON always reported negative net income.
  • In the past 5 years IRON always reported negative operating cash flow.
IRON Yearly Net Income VS EBIT VS OCF VS FCFIRON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • The Return On Assets of IRON (-28.73%) is better than 67.75% of its industry peers.
  • IRON has a Return On Equity of -31.59%. This is in the better half of the industry: IRON outperforms 74.66% of its industry peers.
Industry RankSector Rank
ROA -28.73%
ROE -31.59%
ROIC N/A
ROA(3y)-22.05%
ROA(5y)-23.6%
ROE(3y)-24.43%
ROE(5y)-26.32%
ROIC(3y)N/A
ROIC(5y)N/A
IRON Yearly ROA, ROE, ROICIRON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IRON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IRON Yearly Profit, Operating, Gross MarginsIRON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • IRON has more shares outstanding than it did 1 year ago.
  • IRON has a worse debt/assets ratio than last year.
IRON Yearly Shares OutstandingIRON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
IRON Yearly Total Debt VS Total AssetsIRON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 24.22 indicates that IRON is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 24.22, IRON belongs to the top of the industry, outperforming 90.40% of the companies in the same industry.
  • IRON has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • IRON has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 24.22
ROIC/WACCN/A
WACCN/A
IRON Yearly LT Debt VS Equity VS FCFIRON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 23.45 indicates that IRON has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 23.45, IRON belongs to the best of the industry, outperforming 96.74% of the companies in the same industry.
  • IRON has a Quick Ratio of 23.45. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 23.45, IRON belongs to the top of the industry, outperforming 96.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 23.45
Quick Ratio 23.45
IRON Yearly Current Assets VS Current LiabilitesIRON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for IRON have decreased strongly by -36.83% in the last year.
EPS 1Y (TTM)-36.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-98.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 18.96% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-57.6%
EPS Next 2Y-29.35%
EPS Next 3Y-12.85%
EPS Next 5Y18.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IRON Yearly Revenue VS EstimatesIRON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
IRON Yearly EPS VS EstimatesIRON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IRON. In the last year negative earnings were reported.
  • Also next year IRON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRON Price Earnings VS Forward Price EarningsIRON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRON Per share dataIRON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • IRON's earnings are expected to decrease with -12.85% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-29.35%
EPS Next 3Y-12.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IRON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DISC MEDICINE INC

NASDAQ:IRON (2/20/2026, 8:00:01 PM)

After market: 61.36 0 (0%)

61.36

-1.99 (-3.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners84.86%
Inst Owner Change7.41%
Ins Owners0.42%
Ins Owner Change-9.92%
Market Cap2.32B
Revenue(TTM)N/A
Net Income(TTM)-181.11M
Analysts86.32
Price Target123.25 (100.86%)
Short Float %13%
Short Ratio6.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.09%
Min EPS beat(2)-33.61%
Max EPS beat(2)-18.57%
EPS beat(4)2
Avg EPS beat(4)-6.92%
Min EPS beat(4)-33.61%
Max EPS beat(4)12.77%
EPS beat(8)4
Avg EPS beat(8)-2.73%
EPS beat(12)6
Avg EPS beat(12)-8.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.61%
PT rev (3m)10.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.36%
EPS NY rev (1m)-2.25%
EPS NY rev (3m)-9.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.04
P/tB 4.04
EV/EBITDA N/A
EPS(TTM)-5.35
EYN/A
EPS(NY)-6.68
Fwd EYN/A
FCF(TTM)-4.4
FCFYN/A
OCF(TTM)-4.36
OCFYN/A
SpS0
BVpS15.19
TBVpS15.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.73%
ROE -31.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.05%
ROA(5y)-23.6%
ROE(3y)-24.43%
ROE(5y)-26.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 677.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 23.45
Quick Ratio 23.45
Altman-Z 24.22
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)193.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-98.88%
EPS Next Y-57.6%
EPS Next 2Y-29.35%
EPS Next 3Y-12.85%
EPS Next 5Y18.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75.04%
EBIT Next 3Y-14.43%
EBIT Next 5YN/A
FCF growth 1Y-143.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-141.91%
OCF growth 3YN/A
OCF growth 5YN/A

DISC MEDICINE INC / IRON FAQ

Can you provide the ChartMill fundamental rating for DISC MEDICINE INC?

ChartMill assigns a fundamental rating of 2 / 10 to IRON.


What is the valuation status of DISC MEDICINE INC (IRON) stock?

ChartMill assigns a valuation rating of 0 / 10 to DISC MEDICINE INC (IRON). This can be considered as Overvalued.


What is the profitability of IRON stock?

DISC MEDICINE INC (IRON) has a profitability rating of 1 / 10.